CCMW
TLSA icon

Cypress Capital Management (Wyoming)’s Tiziana Life Sciences TLSA Stock Holding History

Cypress Capital Management (Wyoming)’s Portfolio TLSA Stock Details TLSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-5
Closed – – 286
2021
Q4 		$0 Hold
5
– – ﹤0.01% 307
2021
Q3 		$0 Hold
5
– – ﹤0.01% 308
2021
Q2 		$0 Hold
5
– – ﹤0.01% 320
2021
Q1 		$0 Buy
+5
New +$17 ﹤0.01% 301

Other funds holding TLSA

HighTower Advisors
HighTower Advisors Chicago, Illinois $103B AUM 28.65% 1-Year Est. Return
HSBC Holdings
HSBC Holdings London, United Kingdom $192B AUM 27.2% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
AFP
Ausdal Financial Partners Davenport, Iowa $2.25B AUM 20.11% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Cypress Capital Management (Wyoming)'s TLSA Position: Q1 2022 in Review

Cypress Capital Management (Wyoming) sold out of Tiziana Life Sciences (TLSA) in Q1 2022, closing a stake of 5 shares.

Cypress Capital Management (Wyoming) first reported a position in TLSA in Q1 2021 and held it in 4 quarters. The position peaked at $0 in Q4 2021. 23 funds tracked by Wall St. Rank hold TLSA as of Q1 2022.

  • Cypress Capital Management (Wyoming) reported no remaining Tiziana Life Sciences position as of Q1 2022 after selling out during the quarter.
  • Cypress Capital Management (Wyoming) sold 5 Tiziana Life Sciences shares in Q1 2022.
  • Cypress Capital Management (Wyoming) first reported a position in Tiziana Life Sciences in Q1 2021 and held it in 4 quarters.
  • Cypress Capital Management (Wyoming)'s Tiziana Life Sciences position peaked at $0 in Q4 2021.
  • 23 funds tracked by Wall St. Rank held Tiziana Life Sciences as of Q1 2022.

Based on Cypress Capital Management (Wyoming)'s 13F filing for Q1 2022, filed 9 May 2022.